These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 32645224)

  • 21. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
    Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
    PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic body radiation therapy.
    Avanzo M; Gagliardi V; Stancanello J; Blanck O; Pirrone G; El Naqa I; Revelant A; Sartor G
    Med Phys; 2021 Oct; 48(10):6257-6269. PubMed ID: 34415574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT-based radiomics prediction of complete response after stereotactic body radiation therapy for patients with lung metastases.
    Cilla S; Pistilli D; Romano C; Macchia G; Pierro A; Arcelli A; Buwenge M; Morganti AG; Deodato F
    Strahlenther Onkol; 2023 Jul; 199(7):676-685. PubMed ID: 37256303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
    Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
    Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.
    Coroller TP; Grossmann P; Hou Y; Rios Velazquez E; Leijenaar RT; Hermann G; Lambin P; Haibe-Kains B; Mak RH; Aerts HJ
    Radiother Oncol; 2015 Mar; 114(3):345-50. PubMed ID: 25746350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative CT-based radiomic prognostic index to predict the benefit of postoperative radiotherapy in patients with non-small cell lung cancer: a multicenter study.
    Ma Z; Men Y; Liu Y; Bao Y; Liu Q; Yang X; Wang J; Deng L; Zhai Y; Bi N; Wang L; Hui Z
    Cancer Imaging; 2024 May; 24(1):61. PubMed ID: 38741207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy.
    Bousabarah K; Temming S; Hoevels M; Borggrefe J; Baus WW; Ruess D; Visser-Vandewalle V; Ruge M; Kocher M; Treuer H
    Strahlenther Onkol; 2019 Sep; 195(9):830-842. PubMed ID: 30874846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
    Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
    Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognositc significance of SUV
    Dong M; Liu J; Sun X; Xing L
    J Med Imaging Radiat Oncol; 2017 Oct; 61(5):652-659. PubMed ID: 28266166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-level multi-modality (PET and CT) fusion radiomics: prognostic modeling for non-small cell lung carcinoma.
    Amini M; Nazari M; Shiri I; Hajianfar G; Deevband MR; Abdollahi H; Arabi H; Rahmim A; Zaidi H
    Phys Med Biol; 2021 Oct; 66(20):. PubMed ID: 34544053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy.
    Lafata KJ; Hong JC; Geng R; Ackerson BG; Liu JG; Zhou Z; Torok J; Kelsey CR; Yin FF
    Phys Med Biol; 2019 Jan; 64(2):025007. PubMed ID: 30524018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Oberije C; Monshouwer R; Bussink J; Brink C; Hansen O; Lambin P
    Radiother Oncol; 2017 Jun; 123(3):363-369. PubMed ID: 28506693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT-derived radiomic analysis for predicting the survival rate of patients with non-small cell lung cancer receiving radiotherapy.
    Zhang N; Zhang X; Li J; Ren J; Li L; Dong W; Liu Y
    Phys Med; 2023 Mar; 107():102546. PubMed ID: 36796178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomography-based radiomic model predicts radiological response following stereotactic body radiation therapy in early-stage non-small-cell lung cancer and pulmonary oligo-metastases.
    Cheung BMF; Lau KS; Lee VHF; Leung TW; Kong FS; Luk MY; Yuen KK
    Radiat Oncol J; 2021 Dec; 39(4):254-264. PubMed ID: 34986546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
    Starkov P; Aguilera TA; Golden DI; Shultz DB; Trakul N; Maxim PG; Le QT; Loo BW; Diehn M; Depeursinge A; Rubin DL
    Br J Radiol; 2019 Feb; 92(1094):20180228. PubMed ID: 30457885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition-based radiomic features.
    Soufi M; Arimura H; Nagami N
    Med Phys; 2018 Nov; 45(11):5116-5128. PubMed ID: 30230556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of radiomic features in diagnostic CT images with and without contrast enhancement in the delayed phase for NSCLC patients.
    Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Hirashima H; Matsuo Y; Mizowaki T
    Phys Med; 2020 Jan; 69():176-182. PubMed ID: 31918370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a multi-feature-combined model: proof-of-concept with application to local failure prediction of post-SBRT or surgery early-stage NSCLC patients.
    Yang Z; Wang C; Wang Y; Lafata KJ; Zhang H; Ackerson BG; Kelsey C; Tong B; Yin FF
    Front Oncol; 2023; 13():1185771. PubMed ID: 37781201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms.
    Carloni G; Garibaldi C; Marvaso G; Volpe S; Zaffaroni M; Pepa M; Isaksson LJ; Colombo F; Durante S; Lo Presti G; Raimondi S; Spaggiari L; de Marinis F; Piperno G; Vigorito S; Gandini S; Cremonesi M; Positano V; Jereczek-Fossa BA
    Radiother Oncol; 2023 Jan; 178():109424. PubMed ID: 36435336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomic analysis for early differentiation of lung cancer recurrence from fibrosis in patients treated with lung stereotactic ablative radiotherapy.
    Kunkyab T; Mou B; Jirasek A; Haston C; Andrews J; Thomas S; Hyde D
    Phys Med Biol; 2023 Aug; 68(16):. PubMed ID: 37164024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.